Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Ruck

Showing results (31-40 of 235) with videos related to

Pageof 24
Sort By:
Nature Reviews. Neurology|October 26, 2019
Immune reconstitution therapies: concepts for durable remission in multiple sclerosisJan D Lünemann, Tobias Ruck, Paolo A Muraro, et al.
Frontiers in Neurology|November 12, 2020
Bilateral Vocal Fold Paralysis in Myasthenia Gravis: A Case Report and Literature ReviewChristopher Nelke, Bendix Labeit, Sven G Meuth, et al.
Neurological Research and Practice|December 16, 2020
Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment responseLaura Bierhansl, Tobias Ruck, Steffen Pfeuffer, et al.
Nature Reviews. Drug Discovery|June 6, 2022
Thinking outside the box: non-canonical targets in multiple sclerosisLaura Bierhansl, Hans-Peter Hartung, Orhan Aktas, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 14, 2020
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Drugs|June 4, 2021
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020Niklas Huntemann, Leoni Rolfes, Marc Pawlitzki, et al.
Frontiers in Neurology|July 25, 2019
Dysphagia as Isolated Manifestation of Jo-1 Associated Myositis?Bendix Labeit, Paul Muhle, Sonja Suntrup-Krueger, et al.
Der Nervenarzt|September 20, 2024
[Peripheral neuroimmunological diseases - Neuropathological insights and clinical perspectives]Sarah Hoffmann, Marie-Therese Holzer, Corinna Preuße, et al.
Biomolecules|January 25, 2025
Proteomic Profiling Towards a Better Understanding of Genetic Based Muscular Diseases: The Current Picture and a Look to the FutureMarc Pauper, Andreas Hentschel, Malte Tiburcy, et al.
Frontiers in Immunology|August 28, 2023
S1PR-1/5 modulator RP-101074 shows beneficial effects in a model of central nervous system degenerationMustafa Sindi, Christina Hecker, Andrea Issberner, et al.
Pageof 24

Showing results (31-40 of 235) with videos related to

Sort By:
Pageof 24
Nature Reviews. Neurology|October 26, 2019
Immune reconstitution therapies: concepts for durable remission in multiple sclerosisJan D Lünemann, Tobias Ruck, Paolo A Muraro, et al.
Frontiers in Neurology|November 12, 2020
Bilateral Vocal Fold Paralysis in Myasthenia Gravis: A Case Report and Literature ReviewChristopher Nelke, Bendix Labeit, Sven G Meuth, et al.
Neurological Research and Practice|December 16, 2020
Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment responseLaura Bierhansl, Tobias Ruck, Steffen Pfeuffer, et al.
Nature Reviews. Drug Discovery|June 6, 2022
Thinking outside the box: non-canonical targets in multiple sclerosisLaura Bierhansl, Hans-Peter Hartung, Orhan Aktas, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 14, 2020
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Drugs|June 4, 2021
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020Niklas Huntemann, Leoni Rolfes, Marc Pawlitzki, et al.
Frontiers in Neurology|July 25, 2019
Dysphagia as Isolated Manifestation of Jo-1 Associated Myositis?Bendix Labeit, Paul Muhle, Sonja Suntrup-Krueger, et al.
Der Nervenarzt|September 20, 2024
[Peripheral neuroimmunological diseases - Neuropathological insights and clinical perspectives]Sarah Hoffmann, Marie-Therese Holzer, Corinna Preuße, et al.
Biomolecules|January 25, 2025
Proteomic Profiling Towards a Better Understanding of Genetic Based Muscular Diseases: The Current Picture and a Look to the FutureMarc Pauper, Andreas Hentschel, Malte Tiburcy, et al.
Frontiers in Immunology|August 28, 2023
S1PR-1/5 modulator RP-101074 shows beneficial effects in a model of central nervous system degenerationMustafa Sindi, Christina Hecker, Andrea Issberner, et al.
Pageof 24